SciELO - Scientific Electronic Library Online

 
vol.35 número1Aportes al debate de legalización del uso medicinal de la marihuana en ColombiaEducación para la crianza en un programa de atención a la niñez: lecciones para la salud pública índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Facultad Nacional de Salud Pública

versión impresa ISSN 0120-386X

Resumen

VALENCIA-ARREDONDO, Marleny; HERRERA-POSADA, Daniela; MONTOYA-RODRIGUEZ, Diana  y  NAVALES-ROJAS, Jesenia. Monitoring of women with positive cytological result in a state-owned company, Medellín, Colombia, 2011- 2012. Rev. Fac. Nac. Salud Pública [online]. 2017, vol.35, n.1, pp.27-38. ISSN 0120-386X.  https://doi.org/10.17533/udea.rfnsp.v35n1a04.

In Colombia, the Cervical Cancer (CC) is one of leading causes of cancer death in women. Annually 7,000 cases and 3,300 deaths are diagnosed; from which the 50% have been recorded died for late diagnosis and lack of access to specialized treatments.

Objective

:

This study aims to monitor women who have had a positive cytological results in a state-owned company in Medellin from 2011 to 2012.

Methodology

:

This is a cross-sectional descriptive study conducted on 277 women who had positive cytological results for lesions suggestive of high grade and/or glandular disorders. This research used stratified systematic sampling, and primary and secondary information sources. SPSS was implemented to systematize data like frequency, central tendency, and dispersion measurements were calculated. A descriptive univariate-bivariate analysis was implemented for sociodemographic and clinical related variables, and those related to the healthcare subjects received.

Results

:

10.7% of women with high grade or invasive lesions did not complete the treatment. The total monitoring opportunity was 52.3%, and the phases with the longest-waiting times were waiting for appointments for diagnosis and treatment.

Conclusion

:

Despite efforts to improve screening coverage and to actively seek patients with a positive cytology evidenced in the study, there are still obstacles that impede patients’ prompt diagnosis and treatment, and this is something that in various cases leads to the progression of the disease and even death.

Palabras clave : Monitoring studies; Pap smear; Uterine Cervical Neoplasms; vaginal smear; secondary prevention; diagnosis; Colombia.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )